(Press-News.org) Contact information: Judy Romero
jromero@crf.org
Cardiovascular Research Foundation
Results of the SORT-OUT VI trial presented at TCT 2013
New study compares 2 newer generation drug-eluting stents with biocompatible and biodegradable polymers
	SAN FRANCISCO, CA – October 29, 2013 –  A new study found that both drug-eluting stents (DES) with biocompatible polymers and DES with biodegradable polymers were associated with low major adverse coronary events, demonstrating the non-inferiority of the biocompatible polymer stents in patients undergoing percutaneous coronary intervention (PCI). The findings of the SORT-OUT VI trial were presented today at the 25th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.
	Compared with bare metal stents, first generation DES reduced the risk of restenosis. However, the risk of stent thrombosis was a concern and newer generation DES have been designed to improve efficacy, safety, and device performance. To date, there are no large scale randomized comparison studies of biodegradable polymer-coated stents and biocompatible polymer-coated stents in all-comer populations. The SORT-OUT VI trial investigated the safety and efficacy of a durable but biocompatible polymer coated zotarolimus-eluting stent compared with a biodegradable polymer-coated biolimus-eluting stent in a population-based setting. 
	SORT-OUT VI was a multicenter, all-comer, non-inferiority trial that randomized 2,999 patients with stable coronary artery disease or acute coronary syndromes. The trial was performed within the framework of the Scandinavian Organization for Randomized Trials with Clinical Outcomes, and used patient-driven clinical event detection through Danish health care registries. 
	Patients were randomized to receive either a zotarolimus-eluting permanent polymer stent (n=1,502) or a biolimus-eluting biodegradable stent (n=1,497). The primary endpoint was a composite of major adverse cardiac events including cardiac death, myocardial infarction,	 and target lesion revascularization after 12 months.   
	After 12 months the percentage of patients with major adverse cardiac events was similarly low in both the zotarolimus-eluting and biolimus-eluting stent groups (5.3 percent and 5.1 percent, respectively), demonstrating the non-inferiority of the zotarolimus-eluting stent. 
	"The SORT OUT VI trial found that both zotarolimus-eluting and the biolimus-eluting stents were associated with low major adverse cardiac events," said lead investigator Bent Raungaard MD. Dr. Raungaard is Chief Physician and Associate Professor at Aalborg University Hospital in Denmark. 
	"Further, the zotarolimus-eluting stent was found to be non-inferior to the biolimus-eluting stent for patients treated with PCI."
	###
	The SORT OUT VI trial was supported by unrestricted grants from Biosensors Interventional Technologies Pte Ltd. and Medtronic CardioVascular, Inc. Dr. Raungaard reported no disclosures.
	About CRF and TCT
The Cardiovascular Research Foundation (CRF) is an independent, academically focused nonprofit organization dedicated to improving the survival and quality of life for people with cardiovascular disease through research and education. Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in the lives of countless numbers of patients by establishing the safe use of new technologies and therapies in interventional cardiovascular medicine. CRF is the sponsor of the Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Celebrating its 25th anniversary this year, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine. For more information, visit http://www.crf.org and http://www.tctconference.com.
Results of the SORT-OUT VI trial presented at TCT 2013
New study compares 2 newer generation drug-eluting stents with biocompatible and biodegradable polymers
2013-10-30
ELSE PRESS RELEASES FROM THIS DATE:
Researchers identify way to increase gene therapy success
2013-10-30
Researchers identify way to increase gene therapy success
	Scientists in The Research Institute at Nationwide Children's Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic ...
El Nino events get more extreme as globe warms
2013-10-30
El Nino events get more extreme as globe warms
New method shows how historical ENSO activity is affected by external forcings
	Monday, October 28, 2013: New research shows El Niño Southern Oscillation (ENSO) phenomena have been more active and intense during ...
A therapeutic hypothesis for glucose intolerance after cerebral ischemia
2013-10-30
A therapeutic hypothesis for glucose intolerance after cerebral ischemia
	Interestingly, a recent study found that ischemic stress causes hyperglycemia and may worsen ischemic neuronal damage. In addition, decreased insulin sensitivity after ischemic stress seems ...
Go ahead, dunk your cell phone in salt water
2013-10-30
Go ahead, dunk your cell phone in salt water
	Barrier films, used in everything from food and drug packaging to consumer electronics and solar cells, help prevent your food from spoiling, help to preserve medication, and protect your electronics from damage ...
Scientists announce first results from LUX dark matter detector
2013-10-30
Scientists announce first results from LUX dark matter detector
	PROVIDENCE, R.I. [Brown University] — In its first three months of operation, the Large Underground Xenon (LUX) experiment has proven itself to be the most sensitive dark matter detector in the world, scientists ...
Testing technique could lengthen lifespan of dialysis patients
2013-10-30
Testing technique could lengthen lifespan of dialysis patients
New approach spots deadly hormone imbalances in end-stage kidney disease patients
	Chevy Chase, MD—A new testing method can better detect potentially fatal hormone imbalances in patients with end-stage ...
Low thyroid levels may signal heightened risk of death in hospitalized patients
2013-10-30
Low thyroid levels may signal heightened risk of death in hospitalized patients
Hormone levels help predict survival rate in older individuals with acute illness
	Chevy Chase, MD—Older individuals hospitalized with a serious condition may face a slimmer risk ...
Testosterone production study challenges 25-year-old scientific dogma
2013-10-30
Testosterone production study challenges 25-year-old scientific dogma
New understanding could lead to better treatments for steroid hormone conditions
	Chevy Chase, MD—New research refutes the scientific community's long-held belief that the body needs a specific ...
Scientists digitally reconstruct giant steps taken by dinosaurs for the first time
2013-10-30
Scientists digitally reconstruct giant steps taken by dinosaurs for the first time
1 of the world's largest dinosaurs has been digitally reconstructed by experts from The University of Manchester
	
	
	One of the world's largest dinosaurs has ...
Is left-handedness higher among those suffering from psychosis?
2013-10-30
Is left-handedness higher among those suffering from psychosis?
	Los Angeles, CA (October 30, 2013) Researchers have long studied the connections between hand dominance and different aspects of the human brain. A new study out today in SAGE Open finds that among ...
LAST 30 PRESS RELEASES:
An electronic fiber for stretchable sensing
New image captures spooky bat signal in the sky
Cobalt single atom-phosphate functionalized reduced graphene oxide/perylenetetracarboxylic acid nanosheet heterojunctions for efficiently photocatalytic H2O2 production
World-first study shows Australian marsupials contaminated with harmful ‘forever chemicals’
Unlocking the brain’s hidden drainage system
Enhancing smoking cessation treatment for people living with HIV
Research spotlight: Mapping how gut neurons respond to bacteria, parasites and food allergy
Gordon and Betty Moore Foundation Experimental Physics Investigators awards to UCSB experimentalists opens the door to new insights and innovations
Meerkats get health benefit from mob membership
COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children
How a chorus of synchronized frequencies helps you digest your food
UAlbany researcher partners on $1.2 million NSF grant to explore tropical monsoon rainfall patterns
Checkup time for Fido? Wait might be longer in the country
Genetic variation impact scores: A new tool for earlier heart disease detection
The Lundquist Institute awarded $9 million to launch Community Center of Excellence for Regenerative Medicine
'Really bizarre and exciting': The quantum oscillations are coming from inside
Is AI becoming selfish?
New molten salt method gives old lithium batteries a second life
Leg, foot amputations increased 65% in Illinois hospitals between 2016-2023
Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer
National summit of experts charts unprecedented roadmap to reduce harms from firearms in new ways
Global environmental DNA (eDNA) surveys significantly expand known geographic and ecological niche ranges of marine fish, highlighting current biases in conservation and ecological modeling
Hundreds of animal studies on brain damage after stroke flagged for problematic images
Prize winner’s research reveals how complex neural circuits are correctly wired during brain development
Supershear rupture sustained in thick fault zone during 2025 Mandalay earthquake, study in research package shows
Study reveals how brain cell networks stabilize memory formation
CTE: More than just head trauma, suggests new study
New psychology study suggests chimpanzees might be rational thinkers
Study links genetic variants to higher 'bad' cholesterol and heart attack risk
Myanmar fault had ideal geometry to produce 2025 supershear earthquake
[Press-News.org] Results of the SORT-OUT VI trial presented at TCT 2013New study compares 2 newer generation drug-eluting stents with biocompatible and biodegradable polymers